Trial Profile
Effect of oral neurokinin-1 antagonist, aprepitant for chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving carboplatin/paclitaxel chemotherapy.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Aprepitant; Dexamethasone; Dexamethasone; Granisetron
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 05 Apr 2011 New trial record